MTM Services Underused in Part D Drug Plans

Eileen Oldfield, Associate Editor
Published Online: Friday, August 15, 2014
Follow Pharmacy_Times:
Less than half of Medicare enrollees eligible for MTM services receive consultations from a clinical pharmacist.

Although the US Centers for Medicare and Medicaid Services (CMS) requires all Medicare prescription drug (Part D) plans to provide medication therapy management (MTM) services to beneficiaries meeting certain criteria, less than half of eligible enrollees receive those services.
 
According to an analysis from Avalere Health, CMS estimates 25% of Part D enrollees are eligible for MTM services. Among the top 10 Medicare Part D carriers, however, MTM enrollment rates ranged from 4.6% to 17.5%, for an average of 11% of enrollees receiving the services.
 
In 2012, Medicare beneficiaries were eligible for MTM services if they had at least 2 chronic conditions, were taking at least 3 medications, and had annual drug spending exceeding $3100. Although Part D plans are also required to offer comprehensive medication review (CMR) to all MTM enrollees, Avalere’s analysis showed considerable variation in implementation of those services. CMR enrollment ranged from 2.4 to 74%, with an average of 9.6% of enrollees receiving the services.
 
“With only half of enrollees eligible for MTM programs receiving benefits, the Avalere analysis shows that these valuable services are under-used in Medicare,” Avalere Health CEO Dan Mendelson said in a press release. “As regulators consider reforms, they will need to balance access to services with the operation realities faced by health plans.”
 
Despite the low participation in MTM programs, Medicare Advantage prescription drug plan enrollees were 3 times as likely as those in standalone prescription drug plans to receive CMR. Patients in these plans were 4 times as likely to receive an intervention as a result of CMR, including either outreach to a prescriber or a change in therapy, Avalere reported.


Related Articles
Bipartisan legislation introduced in the U.S. House of Representatives today would formally designate pharmacists as healthcare providers under Medicare Part B. Supported by the National Association of Chain Drug Stores, the bill would amend The Social Security Act of 1935 to enable pharmacists to provide to Medicare patients in underserved communities services that pharmacists already are providing for other patients under state law.
Leaders of Senate and House committees with health care jurisdiction should hold oversight hearings to examine the issues that plagued approximately 50,000 beneficiaries who are covered by Aetna Medicare Part D drug plans.
Community pharmacists are most concerned about below-cost reimbursement for certain generic drugs as well as exclusionary Medicare drug plans according to a survey conducted by the National Community Pharmacists Association that asked its members to help identify the organization’s 2015 priorities.
Provider status would recognize pharmacists as a valued part of the health care team.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$